Literature DB >> 33484007

Increased risk of dementia in hypothyroidism: A Danish nationwide register-based study.

Marianne Thvilum1,2, Frans Brandt3,4, Mads Lillevang-Johansen2,5, Lars Folkestad2,5, Thomas H Brix2,5, Laszlo Hegedüs2,5.   

Abstract

OBJECTIVE: Globally, the prevalence of individuals with dementia is increasing, and identification of risk factors is of paramount interest. Using population-based registers, we evaluated whether hypothyroidism is a risk factor for dementia.
DESIGN: Register-based cohort study. PATIENTS AND METHODS: Risk of dementia was evaluated in two cohorts. The DNPR cohort comprises 111,565 hypothyroid patients, diagnosed between 1995 and 2012, and 446,260 euthyroid age- and sex-matched individuals (median follow-up 6.2 years). The OPENTHYRO cohort comprises 233,844 individuals with at least one measurement of serum thyrotropin (TSH) between 1995 and 2011, of whom 2,894 had hypothyroidism (median follow-up 7.2 years). Primary outcome was dementia defined as an International Classification of Diseases 10 code, or prescription of medicine for dementia.
RESULTS: In the DNPR cohort, risk of dementia was significantly increased in subjects with hypothyroidism (HR 1.22; 95% CI: 1.17-1.27), which attenuated after adjusting for pre-existing comorbidity (HR 0.82; 95% CI: 0.79-0.86). Stratification of age into ≤56 and >56 years showed an inverse relationship between age and risk of dementia (HR≤56 years. 2.03; 95% CI: 1.62-2.53 and HR>56 years . 1.00; 95% CI: 0.96-1.05). In the OPENTHYRO cohort, the risk of dementia was significantly increased for each 6 months of elevated TSH (HR 1.12; 95% CI: 1.07-1.16).
CONCLUSIONS: Hypothyroidism is associated with increased risk of dementia. The association is influenced by comorbidity and age. Every 6 months of elevated TSH increased the risk of dementia by 12%, suggesting that also the length of hypothyroidism influences the risk of dementia.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer's disease; Hashimoto's disease; Hypothyroidism; autoimmunity; register study; vascular dementia

Year:  2021        PMID: 33484007     DOI: 10.1111/cen.14424

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Health-Related Predictors of Changes in Cognitive Status in Community-Dwelling Older Individuals.

Authors:  Caterina Trevisan; Paola Siviero; Federica Limongi; Marianna Noale; Stefania Maggi
Journal:  Front Aging Neurosci       Date:  2022-06-20       Impact factor: 5.702

2.  Autoimmune Disease Classification Based on PubMed Text Mining.

Authors:  Hadas Samuels; Malki Malov; Trishna Saha Detroja; Karin Ben Zaken; Naamah Bloch; Meital Gal-Tanamy; Orly Avni; Baruh Polis; Abraham O Samson
Journal:  J Clin Med       Date:  2022-07-26       Impact factor: 4.964

3.  Patient-Tailored Levothyroxine Dosage with Pharmacokinetic/Pharmacodynamic Modeling: A Novel Approach After Total Thyroidectomy.

Authors:  Vegard Heimly Brun; Amund H Eriksen; Ruth Selseth; Kenth Johansson; Renate Vik; Benedicte Davidsen; Michal Kaut; Lars Hellemo
Journal:  Thyroid       Date:  2021-06-22       Impact factor: 6.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.